The megafund narrative of the last few years has been that these firms provide a solution to the big institutional LP allocation problem; you can park a huge pile of cash and get private market exposure with returns above the cost of capital with minimal stress.
It’s a reasonable premise, and in a world where foundation labs are incinerating billions of dollars there’s even an obvious customer for funds of this scale.
So, we talked about a bifurcation not only of strategy but also of LP base, tapping pools of capital that would otherwise go to some larger bracket of PE before meddling with tiny venture funds. There was some overlap with “traditional venture”, but it didn’t feel threatening.
Then a few things started to change.
First, the big platforms scaled their activity at seed and pre-seed, launching scout programs and accelerators.
Second, platform partners and firms pulled back from their own LP activity in small and emerging firms.
Third, their partners went on a podcast tour to promote the idea that big funds can perform just as well as small funds.
Finally, some have apparently began telling other LPs that small funds are a losing bet, discouraging investment.
Whatever was written from 2023 to 2025 about “bifurcation” appears to have been mistaken. Narratives about a “barbelling” of the market were false. Instead, it appears to be a straight drive toward extreme consolidation.
As a result, even excellent firms on the boutique scale are struggling. Track record is of little value in the face of a dominant narrative that the market has changed forever.
There are a number of innocent explanations. It could simply be bullish enthusiasm for growth and scale. It could be a mistaken projection of AI capital requirements onto all future technology investing. It may all be a hangover of the bad practices of ZIRP.
Another possible explanation is that the big platforms are taking advantage of a frosty market to kill off the competition from small firms, who offer an unfavourable comparison and a constant reminder to traditional LPs that venture capital simply does not scale.
Venture capital does not scale
As funds get larger, they will trend toward worse performance.
There’s a simple mathematical basis for this, in that it’s harder to deliver greater multiples on larger amounts of capital.
There’s a simple incentive basis, in that the career dynamics of a large firm favour finding good looking consensus bets which implicitly offer worse returns.
There’s a risk basis, in that success is rooted in identifying idiosyncratic qualities and that judgement doesn’t scale; you can’t just throw more people at it.
From every observable angle, and for obvious reasons, this is true, and yet the individuals managing large funds would have you believe otherwise; that there are “economies of scale” to be exploited in venture capital.
The fact that there are widespread debates about “kingmaking” in venture capital is the largest and reddest of flags in relation to this. It’s a topic that would be laughed out of the room, were it a room of competent and well-intentioned investors.
It should not, for example, be surprising that the size of early stage rounds is not predictive of success, for if venture capital could be so predictable there would be no need for a venture capital industry in the first place.
It’s an open secret that platform teams are there to manage a larger portfolio of investments for the GPs, rather than to significantly move the needle for founders. In the questionable scheme of venture capital “value-add”, it’s no great edge.
It’s pretty absurd that any of this requires explanation. The idiosyncracy and unpredictability of success in venture capital are self-evident; the industry was built on these two pillars.
Changing the victory condition
It’s clear that venture capital doesn’t scale, and why.
But what if the goal was not to optimise for cash returns, but for predictable markups and volatility laundering at scale?
What if “venture capital”, as a product for large institutional allocators, morphed into a mostly synthetic asset, designed to manipulate portfolio metrics in a manner that exploits their short-term incentives?
In this world, everything is upside down.
Instead of finding outliers and fighting toward an exit, investors just fire capital into the biggest gravity well they can find.
Consensus becomes a superpower for capital coordination, offering simple narratives to sell LPs, pulling more money into the market that will concentrate into the obvious opportunities.
In that world, everything “big venture” touches turns to gold. Charts only go up and to the right. There’s zero friction.
The ideal portfolio in this context is a load of archetypal Stanford/MIT/Harvard founders building AI/SaaS in San Francisco. These companies will be able to most easily raise more capital, regardless of fundamental performance or idiosyncratic quality. With enough money, they may even figure out a business along the way.
You just need to push exits out to 12+ years, and then you can raise 3-5 subsequent funds on your paper performance before anyone starts questioning fund 1 exits. And once you’re at fund 4+, nobody cares about fund 1 anymore anyway.
And every now and then you’ll land a big exit to talk about on podcasts for years after.
The four lies of synthetic venture
To enable this reality, you begin by telling a number of lies.
First, you tell people that there is an ideal founder archetype; the type of person for whom greatness is inevitable, and while there’s only a handful you know where to find them.
Second, you tell people that being based in San Francisco provides such an incredible edge that you’re just not serious if you choose anywhere else.
Third, you tell people that the clear opportunity of the day is (insert category), and that’s where all of the next great companies will come from and you have unique access.
Fourth, you tell people that venture capital has economies of scale and that the ideal firm is a top-to-bottom lifecycle partner to founders with huge reserves and platform support.
It’s a simple checklist of founder, location and company type which becomes the focal point for capital, regardless of any genuine idiosyncratic quality.
Finally, you build the most obviously large “venture” firm in San Francisco, index every deal that matches these criteria and herd vast swathes of capital behind you.
Markup velocity grows, your portfolio booms, the thesis is proven.
Congratulations, you’ve invented the megafund.
Adapting the hypergrowth playbook
Research on historical venture outcomes is clear that all of the behaviours described above are associated with worse returns.
Venture capitalists make predictably bad investment decisions by pattern-matching founders.
The best returns are found outside of San Francisco.
The largest outcomes are rarely in the obvious categories, as excessive attention on a particular category drives up prices but erodes returns through enhanced competition.
Fund size has a convex relationship with success.1
It’s an outlier business, as everyone knows.
Implicitly, doing anything that feels “obvious” is going to generate less alpha, providing less opportunity for outperformance. Eliminating risk with herd behavior will always have a commensurate cost on returns.
The cognitive dissonance occurs because observers have always assumed that generating returns is the goal of venture capital, albeit perhaps lower returns at a larger scale.
However, if your goal is just to grow as large as you can, as fast as you can, to dominate the market and shut-out competitors, then you will gladly market these lies to exploit the deeply flawed relationship between LPs and GPs with a fake product.
In doing so, you will concentrate the market on fewer firms, and fewer companies. Exits will suffer, innovation will slow, and performance will droop, but you will get super fat and happy on your management fees as competence and competition wither out of the market.
Sound familiar?
(top image: “Joseph’s Bloody Coat Brought to Jacob”, by Diego Velazquez)
- Small firms have greater volatility, the greatest chance of extreme outperformance, but $250M to $400M firms appear to be the most consistently performing bracket for early stage venture capital. [↩]

















